Skip to main navigation menu Skip to main content Skip to site footer
Plant Science Today (PST)

Research Articles

Vol. 13 No. 2 (2026)

Plant-derived antimicrobial peptides from Moringa oleifera Lam. against Staphylococcus aureus and its role in treating skin infections: In silico approach

DOI
https://doi.org/10.14719/pst.13227
Submitted
16 December 2025
Published
27-04-2026 — Updated on 07-05-2026
Versions

Abstract

Antimicrobial resistance is one of the emerging health issues in the world today, which has led to the necessity of finding new and effective antimicrobial agents. The medicinal plant Moringa oleifera Lam. was used to determine possible antimicrobial peptides (AMPs) by computational (in silico) techniques. The protein sequences of M. oleifera were retrieved from the National Center for Biotechnology Information (NCBI) and explored through a series of bioinformatics software to predict the peptide regions that have antimicrobial potential. The expected peptide was also characterised in terms of its physicochemical characteristics and structure. Molecular docking of the designed peptide was done to test its interaction with Staphylococcus aureus. This research shows that the in silico method is applicable in the rapid and low-cost screening of bioactive peptides before laboratory testing. The findings showed that the peptide from M. oleifera may be used as a good source of natural AMPs. However, it is advisable to further verify the antimicrobial activity of these peptides experimentally to determine their efficacy and test their application against multidrug-resistant pathogens.

References

  1. 1. MN S. Preventive strategies to combat infections-a review of traditional practices and Ayurveda concepts. Int J Complement Altern Med. 2020;13(3):125–9. https://doi.org/10.15406/ijcam.2020.13.00505
  2. 2. Wahyuni TS, Permanasari AA, Aty Widyawaruyanti W, Hotta H, Aoki-Utsubo C, Hafid AF. Antiviral activity of Indonesian medicinal plants against hepatitis B virus. Pharmacogn J. 2020;12(5):1108–14. https://doi.org/10.5530/pj.2020.12.157
  3. 3. Gupta R, Thakur B, Singh P, Singh HB, Sharma VD, Katoch VM, et al. Anti-tuberculosis activity of selected medicinal plants against multi-drug resistant Mycobacterium tuberculosis isolates. Indian J Med Res. 2010;131(6).
  4. 4. El-Saadony MT, Saad AM, Mohammed DM, Korma SA, Alshahrani MY, Ahmed AE, et al. Medicinal plants: bioactive compounds, biological activities, combating multidrug-resistant microorganisms and human health benefits - a comprehensive review. Front Immunol. 2025;16. https://doi.org/10.3389/fimmu.2025.1491777
  5. 5. Thakur A, Gupta P. Antimicrobial peptides as new antibiotics: a comprehensive review. J Appl Biol Biotechnol. 2024;13(1):22–33. https://doi.org/10.7324/JABB.2025.210174
  6. 6. Singh G, Gupta S, Gupta P. Antibacterials derived from the plants of Lamiaceae: phytochemical framework and mechanistic insights. J Pure Appl Microbiol. 2025. https://doi.org/10.22207/JPAM.19.3.42
  7. 7. Li J, Hu S, Jian W, Xie C, Yang X. Plant antimicrobial peptides: structures, functions and applications. Bot Stud. 2021;62(1):5. https://doi.org/10.1186/s40529-021-00312-x
  8. 8. Abd Rani NZ, Husain K, Kumolosasi. E. Moringa genus: a review of phytochemistry and pharmacology. Front Pharmacol. 2018;9.
  9. 9. https://doi.org/10.3389/fphar.2018.00108
  10. 10. Varinder K, Ajar NY, Puja G. Antimicrobial potential of Moringa oleifera: phytochemicals, mechanisms and nanotechnology applications. Plant Sci Today. 2025. https://doi.org/10.14719/pst.8893
  11. 11. Awdhesh Kumar Mishra R, Kodiveri, Muthukaliannan G. In-silico and in-vitro study of novel antimicrobial peptide AM1 from Aegle marmelos against drug-resistant Staphylococcus aureus. Sci Rep. 2024;14(1):25822. https://doi.org/10.1038/s41598-024-76553-0
  12. 12. Haidari H, Melguizo-Rodríguez L, Cowin AJ, Kopecki Z. Therapeutic potential of antimicrobial peptides for treatment of wound infection. Am J Physiol Physiol. 2023;324(1):C29–38.
  13. 13. https://doi.org/10.1152/ajpcell.00080.2022
  14. 14. Hsu CY, Yousif AM, Abullah KA, Abbas HH, Ahmad H, Eldesoky GE, et al. Antimicrobial peptides (AMPs): new perspectives on their function in dermatological diseases. Int J Pept Res Ther. 2024;30(3):33. https://doi.org/10.1007/s10989-024-10609-7
  15. 15. Zhao Q, He L, Wang X, Ding X, Li L, Tian Y, et al. Characterization of a novel antimicrobial peptide isolated from Moringa oleifera seed protein hydrolysates and its membrane damaging effects on Staphylococcus aureus. J Agric Food Chem. 2022;70(20):6123–33. https://doi.org/10.1021/acs.jafc.2c01335
  16. 16. Sangeeta C, Raman V, Ramachandran C, Deog-Hwan O. Novel phytobiotic - clionasterol from Moringa oleifera leaves against multidrug resistant Staphylococcus aureus. Res J Biotechnol. 2021;16(9).
  17. 17. Apenteng-Takyiako S, Takyi CAA, Chama MA, Osei MM, Donkor ES, Futagbi G. In vitro antibacterial activity of Moringa oleifera leaf and seed extracts against antibiotic-resistant bacteria and clinical isolates. BMC Complement Med Ther. 2025;25(1):257. https://doi.org/10.1186/s12906-025-05006-6
  18. 18. Pfalzgraff A, Brandenburg K, Weindl G. Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds. Front Pharmacol. 2018;9. https://doi.org/10.3389/fphar.2018.00281
  19. 19. Helmerhorst EJ, Reijnders IM, van 't Hof W, Veerman EC, Nieuw Amerongen AV. A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides. FEBS Lett. 1999;449(2-3):105–10. https://doi.org/10.1016/S0014-5793(99)00411-1
  20. 20. Farag MR, Alagawany M. Erythrocytes as a biological model for screening of xenobiotics toxicity. Chem Biol Interact. 2018;279:73–83. https://doi.org/10.1016/j.cbi.2017.11.007
  21. 21. Kim SH, Min YH, Park MC. Antimicrobial peptides: current status, mechanisms of action and strategies to overcome therapeutic limitations. Microorganisms. 2025;13(11):2574. https://doi.org/10.3390/microorganisms13112574
  22. 22. Le CF, Fang CM, Sekaran SD. Intracellular targeting mechanisms by antimicrobial peptides. Antimicrob Agents Chemother. 2017;61(4). https://doi.org/10.1128/AAC.02340-16
  23. 23. Shao C, Zhu Y, Lai Z, Tan P, Shan A. Antimicrobial peptides with protease stability: progress and perspective. Future Med Chem. 2019;11(16):2047–50. https://doi.org/10.4155/fmc-2019-0167
  24. 24. Pei Z, Song Q, Xu J, Yu S, Ma H. The cyclic antimicrobial peptide C-LR18 has enhanced antibacterial activity, improved stability and a longer half-life compared to the original peptide. Antibiotics. 2025;14(3):312. https://doi.org/10.3390/antibiotics14030312
  25. 25. Wang G. Improved methods for classification, prediction and design of antimicrobial peptides. Methods Mol Biol. 2015;43–66. https://doi.org/10.1007/978-1-4939-2285-7_3
  26. 26. Fishovitz J, Hermoso JA, Chang M, Mobashery S. Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. IUBMB Life. 2014;66(8):572–7. https://doi.org/10.1002/iub.1289

Downloads

Download data is not yet available.